DEBRA KING: Open Payments
NPI 1295842151 · ATHENS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 26 payments from 9 companies in 2025. Trend: 2023 $1,329 · 2024 $1,489 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $145 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| Lilly USA, LLC | 2 | $36 |
| PFIZER INC. | 2 | $34 |
| Novo Nordisk Inc | 2 | $31 |
| Amgen Inc. | 1 | $18 |
| Medtronic, Inc. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: VRAYLAR, Kerendia, UBRELVY, AIRSUPRA, QULIPTA, NURTEC ODT, JARDIANCE, EVENITY.
Industry payments across OH — which companies pay providers there.
